FISIOLOGÍA Y FARMACOLOGÍA
Departamento
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (10)
2024
-
Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 3, pp. 851-859
2023
-
Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing
International Journal of Molecular Sciences, Vol. 24, Núm. 22
-
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma
Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108
2021
-
Management of acquired hemophilia A: results from the Spanish registry
Blood Advances, Vol. 5, Núm. 19, pp. 3821-3829
2020
2017
-
Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver
Journal of Lipid Research, Vol. 58, Núm. 9, pp. 1903-1915
-
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Hepatology, Vol. 66, Núm. 4, pp. 1125-1143
2016
-
Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction
Blood, Vol. 128, Núm. 9, pp. 1282-1289
2011
-
Diminished thrombogenic responses by deletion of the Podocalyxin gene in mouse megakaryocytes
PLoS ONE, Vol. 6, Núm. 10
-
Release of podocalyxin into the extracellular space. Role of metalloproteinases
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1813, Núm. 8, pp. 1504-1510